Status:

TERMINATED

Lokomat Training Effects on MS Gait Abnormalities

Lead Sponsor:

US Department of Veterans Affairs

Conditions:

Multiple Sclerosis

Eligibility:

All Genders

18-75 years

Phase:

PHASE1

PHASE2

Brief Summary

Multiple sclerosis is a degenerative disease that affects more than 400,000 people in the US alone. MS is in fact the most common disabling neurological disorder in young adults. Symptoms of the disea...

Eligibility Criteria

Inclusion

  • Diagnosis of MS by McDonald criteria
  • Ability to clearly understand written and oral direction in English
  • Self-reported gait problem
  • One or more falls in the past 6 months
  • The ability to walk 25 feet with no more than a cane for assistance (The subject must be comfortable using a cane)
  • Age 18-70
  • Written informed consent to participate in the study
  • Approval from subject's primary care physician for physical activity

Exclusion

  • No relapse within the last 3 months
  • No more than two relapses within the past 12 months
  • Recent myocardial infarction
  • Uncontrolled hypertension or diabetes
  • Symptomatic fall in blood pressure when standing
  • Vascular claudication or pitting edema
  • Cognitive impairments that limit comprehension of protocol instructions (assessed by Comprehension Test of Consent Form)
  • Body weight over 150 kg
  • FES-I \< 25
  • Lower extremity injuries that limit range of motion or function
  • Joint problems (hip or leg) that limit range of motion or cause pain with movement
  • Unstable fractures
  • Pressure sores with any skin breakdown in areas in contact with the body harness or the robot-driven gait orthotic apparatus
  • Currently enrolled in an alcohol or drug treatment program
  • A complicating medical condition that would prevent completion of the trial
  • Enrolled in or planning to enroll in another interventional research trial using procedures proposed to enhance or limit the function of the upper or lower extremities (such as adjuvant rehabilitation or Botox injections) during the 24 weeks of participation
  • A difference of more than 2cm between subjects' right and left leg lengths
  • Unable to be properly fit into the harness or Lokomat device
  • Hypertonicity or spasticity that it interferes with a proper fit into the Lokomat
  • Pregnancy at enrollment, as determined by a home pregnancy test kit at screening visit

Key Trial Info

Start Date :

June 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2008

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT00766272

Start Date

June 1 2008

End Date

June 1 2008

Last Update

September 23 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Providence VA Medical Center

Providence, Rhode Island, United States, 02908-4799